| 1 |
29689274 | The mechanistic effects of the dioxonaphthoimidazolium analog YM155 in renal cell carcinoma cell cycling and apoptosis. | 2018 Jun 15 |
1 |
| 2 |
27241169 | YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy. | 2016 Jun 8 |
1 |
| 3 |
25220225 | YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells. | 2015 Jan |
2 |
| 4 |
25948188 | [Effect of YM155 on Apoptosis and Autophagy of K562 Cells]. | 2015 Apr |
2 |
| 5 |
26081496 | YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and in vivo. | 2015 Aug |
1 |
| 6 |
26118775 | AML sensitivity to YM155 is modulated through AKT and Mcl-1. | 2015 Sep 28 |
1 |
| 7 |
23618862 | YM155 induces caspase-8 dependent apoptosis through downregulation of survivin and Mcl-1 in human leukemia cells. | 2013 May 24 |
3 |
| 8 |
24432379 | Synergistic antitumor activities of sepantronium bromide (YM155), a survivin suppressant, in combination with microtubule-targeting agents in triple-negative breast cancer cells. | 2013 |
1 |
| 9 |
23267699 | Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells. | 2012 Dec 26 |
1 |
| 10 |
20517311 | Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs. | 2010 Jun 29 |
1 |